Mette Agger - Profile and Investment Details

Investor Profile

Mette Agger is a Venture Capital based in Denmark with a diverse investment portfolio that includes companies such as BONESUPPORT, Syntaxin, Amplyx Pharmaceuticals, IO Biotech, Cydan, Biom'Up, LEXEO Therapeutics, VarmX, SANIFIT, Aura Biosciences, Ziarco, Nexstim, scPharmaceuticals, Imara, Psioxus Therapeutics, Thesan PharmaceuticalsAsante Solutions, River Vision Development, Reneo Pharmaceuticals, Iconic Therapeutics, ENTEROME, Atox Bio, Vtesse, AlloCure, Celladon, DYSIS Medical, Spero Therapeutics, Acacia Pharma, SNIPR Biome, Trevi Therapeutics, DBV Technologies, Tiburio Therapeutics, VHSquared, . Over time, Mette Agger has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Mette Agger is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Women Founded, Life Science, Manufacturing, Biotechnology, Hispanic / Latinx Founded, Genomics, Clinical Trials, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Mette Agger, as their portfolio suggests a familiarity and interest in this area.

Understanding Mette Agger’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.